Table 2.
Exchange Transfusion, ml/kg |
|||||
---|---|---|---|---|---|
0 | 10 | 20 | 30 | P | |
Hb, g/dl | 13.5 ± 1.5 | 12.4 ± 0.8 | 11.8 ± 0.4 | 11.4 ± 0.3 | * |
Hematocrit, % | 40.3 ± 3.3 | 31.8 ± 3.8 | 26.5 ± 1.3 | 23.2 ± 1.4 | * |
Mean alveolar Po2, Torr | 141 ± 3 | 141 ± 6 | 137 ± 7 | 135 ± 2 | |
Heart rate, beats/min | 119 ± 5 | 107 ± 11 | 100 ± 22 | 106 ± 10 | |
Pulmonary blood flow, ml · (min · kg)−1 | 121 ± 5 | 114 ± 20 | 119 ± 18 | 109 ± 10 | |
End-expiratory lung volume, ml/kg | 32 ± 5 | 32 ± 5 | 31 ± 5 | 31 ± 8 | |
End-inspiratory lung volume, ml/kg | 84 ± 5 | 84 ± 4 | 83 ± 5 | 83 ± 8 | |
Septal tissue volume, ml/kg | 5.10 ± 2.15 | 4.88 ± 1.84 | 3.80 ± 1.45 | 4.30 ± 1.92 | |
DlCO, ml · (min · Torr · kg)−1 | 0.61 ± 0.05 | 0.61 ± 0.10 | 0.61 ± 0.06 | 0.60 ± 0.03 | |
DlNO, ml · (min · Torr · kg)−1 | 2.69 ± 0.44 | 3.01 ± 0.57 | 3.81 ± 0.92 | 4.27 ± 1.08 | * |
Method 1 (RF) | |||||
DmCO, ml · (min · Torr · kg)−1 | 1.08 ± 0.11 | 1.07 ± 0.23 | 1.21 ± 0.10 | 1.01 ± 0.21 | |
Vc, ml/kg | 2.75 ± 0.33 | 2.96 ± 0.19 | 2.73 ± 0.26 | 3.47 ± 0.64 | * |
Method 2 (NO-CO, θNO = ∞) | |||||
DmCO, ml · (min · Torr · kg)−1 | 1.15 ± 0.19 | 1.29 ± 0.29 | 1.63 ± 0.39 | 1.82 ± 0.46 | *† |
Vc, ml/kg | 2.57 ± 0.33 | 2.42 ± 0.22 | 2.18 ± 0.05 | 2.06 ± 0.35 | *† |
Method 3 (NO-CO, θNO = 4.5) | |||||
DmCO, ml · (min · Torr · kg)−1 | 2.23 ± 0.70 | 2.68 ± 0.86 | 4.55 ± 2.28 | 4.28 ± 2.31 | † |
Vc, ml/kg | 1.70 ± 0.25 | 1.66 ± 0.12 | 1.52 ± 0.06 | 1.66 ± 0.03 | † |
Values are means ± SD. RF, Roughton-Forster method using θCO from Eq. 4. NO-CO method assumes DlNO/DmCO = 2.34 and θNO = ∞ or θNO = 4.5. Repeated-measures ANOVA and post hoc Fisher's protected least significant difference:
P < 0.05 vs. exchange transfusion;
P < 0.05 vs. method 1.